COMPARISON OF 10-DAY SEQUENTIAL THERAPY WITH BISMUTH BASED QUADRUPLE THERAPY FOR SECOND LINE HELICOBACTER PYLORI ERADICATION

被引：0
|
作者：
Jang, B. [1 ]
Kim, S. [1 ]
Lee, S. [1 ]
Yang, C. [2 ]
机构：
[1] Yeungnam Univ, Coll Med, Taegu, South Korea
[2] Dongguk Univ, Coll Med, Taegu, South Korea
来源：
HELICOBACTER | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P11.33
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [31] Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication
    Korman, MG
    Bolin, TD
    Engelman, JL
    Pianko, S
    HELICOBACTER, 1997, 2 (03) : 140 - 143
  • [32] 10-Days Concomitant Therapy, 10-Day Bismuth Quadruple Therapy, and 14-Day Triple Therapy in the First Line Treatment of Helicobacter Pylori Infection - A Multicenter Randomized Trial
    Chen, Po-Yueh
    Liou, Jyh-Ming
    Fang, Yu-Jen
    Chen, Chieh-Chang
    Chang, Chi-Yang
    Wu, Jeng-Yih
    Bair, Ming-Jong
    Lin, Jaw-Town
    Wu, Ming-Shiang
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (01) : 155 - +
  • [33] Sequential versus concomitant non-bismuth quadruple therapy as first-line eradication for helicobacter pylori
    Pereira, F.
    Azevedo, R.
    Linhares, M.
    Ramos, D.
    Pinto, J.
    Caldeira, A.
    Tristan, J.
    Pereira, E.
    Sousa, R.
    Banhudo, A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [34] Twice-daily intake of bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: A retrospective study on 10-day, 14-day, and half-dose antibiotic therapy
    Lee, Sun-Young
    Kim, Jeong Hwan
    Sung, In-Kyung
    Park, Hyung Seok
    HELICOBACTER, 2023, 28 (04)
  • [35] COMPARISON OF THE EFFICACY OF 10 DAY-TRIPLE THERAPY-BASED, BISMUTH- CONTAINING QUADRUPLE THERAPY WITH TRIPLE THERAPY FOR THE FIRST LINE THERAPY OF HELICOBACTER PYLORI
    Moon, B. S.
    Yi, S. W.
    Lim, H. C.
    Lee, Y. C.
    HELICOBACTER, 2015, 20 : 93 - 93
  • [36] Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial
    Kuo, Chao-Hung
    Hsu, Ping-I
    Kuo, Fu-Chen
    Wang, Sophie S. W.
    Hu, Huang-Ming
    Liu, Chung-Jung
    Chuah, Seng-Kee
    Chen, Yen-Hsu
    Hsieh, Ming-Chia
    Wu, Deng-Chyang
    Tseng, Hui-Hwa
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (01) : 222 - 228
  • [37] Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection
    Kim, Jeemyoung
    Gong, Eun Jeong
    Seo, Myeongsook
    Seo, Hyun Il
    Park, Jong Kyu
    Lee, Sang Jin
    Han, Koon Hee
    Jeong, Woo Jin
    Kim, Young Don
    Cheon, Gab Jin
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [38] The efficacy of 10 day-triple therapy-based, bismuth-containing quadruple therapy for the first line therapy of Helicobacter pylori
    Moon, B. S.
    Yi, S. W.
    Lim, H. C.
    Lee, Y. C.
    HELICOBACTER, 2018, 23
  • [39] Second-line treatment for helicobacter pylori infection: 10-day moxifloxacin-based triple therapy vs. 2-week quadruple therapy
    Kang, Jung Mook
    Kim, Nayoung
    Lee, Dong Ho
    Park, Young Su
    Kim, Yu Rim
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    GASTROENTEROLOGY, 2008, 134 (04) : A331 - A331
  • [40] The Efficacy of Bismuth based Quadruple and Sequential Therapies in Helicobacter pylori Eradication
    Coskun, Adil
    Celik, Mustafa
    Kandemir, Altay
    MEANDROS MEDICAL AND DENTAL JOURNAL, 2020, 21 (02): : 111 - 116
12345